NEW POSITIVE ACTION STRATEGY & FUNDING
Strategy & Funding Themes
The ViiV Healthcare Positive Action strategy 2020- 2030 was launched in December 2019.
Click here to download our high-level strategy.
The strategy works towards achieving healthy communities in a world free of AIDS and supports ViiV’s mission of leaving no person living with HIV behind.
Positive Action has developed a logic framework which demonstrates how we will achieve our overall strategy.
Information for grantees who have received funding under the previous programmes (PACF, PAGW, PA, PA MSM&T and PA Europe can be found here).
The new Positive Action strategy has three categories of funding. Challenges, Community Strategic Initiatives and Breakthrough.
For any questions relating to the Positive Action strategy 2020 - 2030 or the funding rounds please send an email to WW.PositiveAction@viivhealthcare.com”
Positive Action invites applications to the Round 1 funding for Innovator Grants focusing on HIV-related Stigma under two themes:
- HIV Self stigma (Global call)
- Addressing HIV- related Stigma in Middle East and North Africa (MENA) –closed call only to eligible countries in MENA. (see list of eligible countries here)
Your application should be specific in describing how the interventions that you want to implement is going to contribute to addressing self-stigma and/or HIV-related Stigma. Applicants should also be cognisant that interventions can focus on individual, family, community and structural level or any combination of levels.
Requests for proposals will be open from 07 June 2020 (00:01 GMT) to 19 July 2020 (23:59 GMT) 2020. Applications will be reviewed by the Technical Review Committee at their meeting in August 2020.
Community-based organisations will be supported with individual grants of £30, 000-£50,000 per year over two years (about £80,000–£100,000 over the two-year period (more information here).
Community Strategic Initiatives
Positive’s Action invites applications to the Round 1 funding for Innovator Grants focusing on HIV-related stigma under two themes:
Innovator grants: £30 000 - £50 000 per year over two years. These grants are focussed on funding novel or innovative interventions at the community level.
Funding Round 1: Innovator Grants - Opens 7 June 2020 at 00h01 BST and closes on 19 July 2020 at 23h59 BST
Theme: HIV-related Stigma focussing on two components.
- HIV self-stigma (global call).
- Addressing HIV-related stigma in the Middle East and North Africa (limited to countries in MENA)
Click here to download a more detailed guidance note for these themes.
All applications must be submitted through the Cyber Grants Portal. You will need to register your profile to gain access even if you have been a previous Positive Action Grantee.
Completing Your Application
To create your profile, you will first need to complete this short quiz to select which of the two themes you are eligible to apply for.
Please do not email applications to ViiV Healthcare or Positive Action staff members or Positive Action mailboxes. We will only accept applications via the online application system.
If you have any problems accessing the online system please review Appendix 2, the FAQs in the detailed guidance document and/or contact the Positive Action mailbox. WW.PositiveAction@viivhealthcare.com
The application window is open until 19th July 2020. Applications will be reviewed by a Technical Review committee week commencing 03 August 2020. Final decision and contracting will happen week commencing 14 September onwards.
These dates are provided as a guide.
Community Emergency Response Fund
ViiV Healthcare’s COVID19 Community Emergency Response Fund supported community-based organisations in their work to address the specific challenges that have arisen for people living with HIV or affected by HIV as a result of the COVID-19 pandemic.
Proposals were received in the following thematic areas:
- Support for ongoing access to critical HIV prevention, care and treatment services (adherence support interventions, psychosocial support, strengthening access to ARVs, strategies for hard to reach populations, etc.)
- Capacity building to support the transition of service delivery from face to face service delivery to home or digital services etc.
- Short term payments for critical community staff who are responding to COVID19 challenges (salaries, airtime, data, transport costs etc.)
- Community monitoring and community feedback mechanisms on impact of COVID19 HIV services and support.
All recommended applicants have now been informed of the outcome. If you have not heard from the Positive Action team you can assume that your application has been unsuccessful.
Positive Action Challenges seek to find innovative solutions to a particular issue or challenge.
We are pleased to announce the selected award recipients of the most recent Challenge we ran in partnership with IAS and INPUD. This Challenge invited applications that focus specifically on community or peer-led initiatives that aim to provide comprehensive, innovative and accessible harm reduction services at the community level for people who inject drugs.
The following organisations were selected due to meeting some or all of the following criteria:
- Community or peer-led.
- Meaningfully engaging and involving the community of people who inject drugs in the design and delivery of their initiative.
- Promoting non-stigmatising, inclusive and comprehensive care for people who use drugs.
- Describing how harm reduction services can be integrated into existing community or local public health HIV support services.
- Being able to demonstrate how the initiative drives increased and sustained access to HIV services and support through addressing current barriers.
- Demonstrating how the project can be sustained beyond the award.
Seed award recipients to pilot a new idea:
Grand award recipient to scale a proven project:
Hear from Stephen Rea, Head of ViiV Communications and Government Affairs, and our sponsors, IAS and INPUD at AIDS2020: Virtual below:
The Review Panel
Other members of the review panel
HIV infections among people who inject drugs are rising. People who inject drugs and their sexual partners accounted for around one fifth of all people newly infected with HIV (outside of sub-Saharan Africa) in 2018. In two regions of the world—eastern Europe and central Asia and the Middle East and North Africa—people who inject drugs accounted for more than one third of new infections in 2018. Viral hepatitis and tuberculosis rates among people who use drugs are also high in many parts of the world. These preventable and treatable diseases, combined with overdose deaths, which are also preventable, are claiming hundreds of thousands of lives each year. In many countries across the globe, injecting drug use is not often acknowledged, and a public health response therefore not implemented.
Harm reduction is rooted in a commitment to addressing discrimination and ensuring that nobody is excluded from the health and social services they may need because of their drug use, their race, their gender, their gender identity, their sexual orientation, their choice of work, or their economic status. The meaningful involvement of people who use drugs in designing, implementing and evaluating programmes and policies that serve them is central to harm reduction.
Comprehensive harm reduction services — including needle–syringe programmes, opioid substitution therapy, drug dependence treatment, overdose prevention and testing and treatment for HIV, tuberculosis and hepatitis B and C— reduce the incidence of blood-borne infections, overdose deaths and other harms.
Breakthrough grants focus on strategic partnerships aimed at achieving targeted and strategic impact in order to achieve HIV targets more effectively and efficiently. The two thematic areas for 2020 – 2023 is focusing on ending paediatric AIDS by 2025 and ending AIDS amongst people who use drugs.
Breakthrough grants are only available by invitation.